<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JOCR</journal-id><journal-title-group><journal-title>Journal of Organic Chemistry Research</journal-title></journal-title-group><issn pub-type="epub">2330-5231</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/JOCR.2016.44013</article-id><article-id pub-id-type="publisher-id">JOCR-19131</article-id><article-categories><subj-group subj-group-type="heading"><subject>JOCR20160400000_33937638.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>化学与材料</subject></subj-group></article-categories><title-group><article-title>
 
 
  磷钨酸促进的酰肼与查尔酮缩合反应的研究
  Study on the Condensation Reaction of Hydrazide with Benzylideneacetophenone Catalyzed by Phosphotungstic Acid
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>吴</surname><given-names>阳</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>邢</surname><given-names>雪建</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>邢</surname><given-names>刘桩</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>侯</surname><given-names>亚东</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>杨</surname><given-names>敬辉</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>惠</surname><given-names>永海</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>新疆大学化学化工学院，新疆 乌鲁木齐</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>02</day><month>12</month><year>2016</year></pub-date><volume>04</volume><issue>04</issue><fpage>93</fpage><lpage>99</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   
   本文以杂多酸–磷钨酸为催化剂，对酰肼与查尔酮的缩合反应进行了研究。经过一系列反应条件的筛选，确立了最佳反应条件，并对底物的普适性进行了考察，得到了一系列高产率的酰腙类目标产物，最高产率达到99%。本反应操作简单，条件温和，为查尔酮酰腙合成提供了一种新的方法。 The condensation of hydrazide with benzylideneacetophenone was studied by using phospho-tungstic acid as catalyst. After a series of reaction conditions, the optimal reaction conditions were established, and the universality of the substrate was investigated. A series of acylhydrazones were obtained with the high yields, up to 99%. The reaction was simple and mild, which provided a new method for the synthesis of chalcone hydrazone.
    
  
 
</p></abstract><kwd-group><kwd>杂多酸，缩合反应，酰腙, Heteropoly Acid</kwd><kwd> Condensation Reaction</kwd><kwd> Acylhydrazone</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>磷钨酸促进的酰肼与查尔酮缩合反应的研究<sup> </sup></title><p>吴阳，邢雪建，邢刘桩，侯亚东，杨敬辉，惠永海<sup>*</sup></p><p>新疆大学化学化工学院，新疆 乌鲁木齐</p><p>Email: <sup>*</sup>hyhai97@126.com</p><p>收稿日期：2016年11月1日；录用日期：2016年11月28日；发布日期：2016年12月2日</p><disp-formula id="hanspub.19131-formula168"><graphic xlink:href="http://html.hanspub.org/file/1-2970069x6_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>本文以杂多酸–磷钨酸为催化剂，对酰肼与查尔酮的缩合反应进行了研究。经过一系列反应条件的筛选，确立了最佳反应条件，并对底物的普适性进行了考察，得到了一系列高产率的酰腙类目标产物，最高产率达到99%。本反应操作简单，条件温和，为查尔酮酰腙合成提供了一种新的方法。</p><p>关键词 :杂多酸，缩合反应，酰腙</p><disp-formula id="hanspub.19131-formula169"><graphic xlink:href="http://html.hanspub.org/file/1-2970069x7_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s3"><title>1. 引言</title><p>酰腙是一类含有−CONHN = CH−基团的人工合成的化合物，通过酰肼与醛或酮缩合反应制得。因其分子结构中含有亚胺基(−CH = N−)故又属于席夫碱。在生物活性体系中体现出突出的抗菌、抗真菌、抗癌、脲酶抑制、抗氧化和抗糖化等良好的生理活性 [<xref ref-type="bibr" rid="hanspub.19131-ref1">1</xref>] - [<xref ref-type="bibr" rid="hanspub.19131-ref7">7</xref>] 。另外，酰腙类化合物与过渡金属、稀土金属等有着很强的配位能力，可以衍生出很多具有较高生物活性的金属配合物 [<xref ref-type="bibr" rid="hanspub.19131-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.19131-ref9">9</xref>] [<xref ref-type="bibr" rid="hanspub.19131-ref10">10</xref>] 。所以，在农药、医药、催化、分析和材料等方面有着广泛应用 [<xref ref-type="bibr" rid="hanspub.19131-ref11">11</xref>] [<xref ref-type="bibr" rid="hanspub.19131-ref12">12</xref>] [<xref ref-type="bibr" rid="hanspub.19131-ref13">13</xref>] [<xref ref-type="bibr" rid="hanspub.19131-ref14">14</xref>] [<xref ref-type="bibr" rid="hanspub.19131-ref15">15</xref>] ，多年来一直备受人们的广泛关注。也引起了很多化学和生物学工作者们的极大兴趣，成为越来越活跃的研究领域之一。</p><p>本文以苯甲酰肼和查尔酮为原料，通过条件筛选得到最佳反应条件。在最佳条件下，合成了一系列收率较好的查尔酮苯甲酰腙衍生物。为合成酰腙的衍生物寻找一种简单的合成方法。</p></sec><sec id="s4"><title>2. 实验部分</title><sec id="s4_1"><title>2.1. 试剂与仪器</title><p>薄层层析硅胶用GF254硅胶和300-400目柱层析硅胶(青岛海洋化工厂)。常见的显色方式有：ZF-2型三用紫外仪，碘缸，酸性溶液，茚三酮等，熔点是由X-4数字显示显微熔点仪测定。元素分析用EA-1110元素分析仪测定。核磁共振是有VARIAN INOVA-400型核磁共振波谱仪测定，核磁氢谱的内标为TMS (δ = 0.00)，核磁碳谱的内标为CDCl<sub>3</sub> (δ = 77.00)。常用试剂：石油醚、乙酸乙酯、甲醇、无水乙醇和二氯甲烷等分析纯试剂是由市售购买而来，未经处理直接使用。苯甲醛、苯乙酮、取代芳香醛、取代芳香酮和芳香胺等是购买于阿拉丁化学厂家，其中对有些不纯的底物在做反应时经过了纯化。</p></sec><sec id="s4_2"><title>2.2. α,β-不饱和酮的合成</title><p>α,β-不饱和酮的合成参照文献 [<xref ref-type="bibr" rid="hanspub.19131-ref16">16</xref>] 。</p></sec><sec id="s4_3"><title>2.3. 目标化合物4a~4q的合成及结构分析</title><p>化合物4a~4q的合成反应如图1所示。以化合物4a为例，向反应管中依次加入查尔酮0.0208 g (0.10 mmol)，</p><p>图1. 查尔酮苯甲酰腙衍生物(4a~4p)的合成</p><p>苯甲酰肼0.0204 g (0.15 mmol)，磷钨酸0.0042 g (0.15 mmol%)，0.5 mL甲醇，在室温反应24 h，TLC跟踪反应情况，反应完毕后减压浓缩，得粗产物，经柱层析分离纯化，得到白色固体(洗脱液为V1(石油醚):V2(乙酸乙酯) = 1:30，1:20，1:10，1:5)。目标化合物的表征如下：</p><p>4a: (Z)-Nˊ-((E)-1,3-diphenylallylidene) benzohydrazide, White solid; 96% yield; m.p. 154~157˚C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.98 (s, 1H), 7.66~7.27 (m, 15H), 6.42 (d, J = 16.4 Hz, 1 H). Anal. Calcd. (%) for C<sub>22</sub>H<sub>18</sub>N<sub>2</sub>O:C, 80.96; H, 5.56; N, 8.59. Found (%): C, 81.07; H, 5.52; N, 8.49.</p><p>4b: (Z)-Nˊ-((E)-1-(4-chlorophenyl)-3-phenylallylidene)benzohydrazide, Yellow solid; 92% yield; m.p. 161-163˚C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>):δ 8.89(s, 1 H), 7.58~7.26 (m, 14 H), 6.38 (d, J = 16.4 Hz, 1 H). Anal. Calcd. (%) for C<sub>22</sub>H<sub>17</sub>ClN<sub>2</sub>O:C, 73.23; H, 4.75; N, 7.76. Found (%): C, 73.44; H, 4.71; N, 7.69.</p><p>4c: (Z)-Nˊ-((E)-1-(4-bromophenyl)-3-phenylallylidene) benzohydrazide, White solid; 94% yield; m.p. 173-175˚C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>):δ 8.89 (s, 1 H), 7.87~7.19 (m, 14 H), 6.37 (d, 1 H, J = 16.8 Hz). Anal. Calcd. (%) for C<sub>22</sub>H<sub>17</sub>BrN<sub>2</sub>O: C, 65.20; H, 4.23; N, 6.91. Found (%): C, 65.37; H, 4.19; N, 6.84.</p><p>4d: (Z)-Nˊ-((E)-3-phenyl-1-(p-tolyl) allylidene) benzohydrazide, Yellow oil; 83% yield; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.03 (s, 1 H), 7.56 (d, J = 7.2 Hz, 1 H), 7.48~7.38 (m, 10 H ), 7.34~7.27 (m, 2 H), 6.44 (d, J = 16.2 Hz, 1H), 2.49 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ: 163.16, 156.79, 140.25, 138.26, 136.13, 133.21, 131.99, 130.59, 129.16, 129.06, 128.95, 128.79, 128.67, 128.41, 128.10, 127.52, 1227.12, 21.52. Anal. Calcd. (%) for C<sub>23</sub>H<sub>20</sub>N<sub>2</sub>O: C, 81.15; H, 5.92; N, 8.23. Found (%): C, 81.29; H, 5.83; N, 8.11.</p><p>4e: (Z)-Nˊ-((E)-1-(4-methoxyphenyl)-3-phenylallylidene) benzohydrazide, Yellow oil; 90% yield; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.07 (s, 1 H), 7.59-7.57 (m, 2 H), 7.52-7.25 (m, 10 H), 7.15-7.13 (m, 2 H), 6.46 (d, J = 16.4 Hz, 1 H), 3.90 (s, 3 H). Anal. Calcd. (%) for C<sub>23</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub>: C, 77.51; H, 5.66; N, 7.86. Found (%): C, 77.75; H, 5.57; N, 7.73.</p><p>4f: (Z)-Nˊ-((E)-1-(3-chlorophenyl)-3-phenylallylidene) benzohydrazide, White solid; 75% yield; m.p. 122-124˚C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.88 (s, 1 H), 7.99~7.83 (m, 2 H), 7.74~7. 57 (m, 3 H), 7.53~7.26 (m, 8 H), 7.28~7.26 (m, 1 H), 6.40 (d, J = 16 Hz, 1 H). Anal. Calcd. (%) for C<sub>22</sub>H<sub>17</sub>ClN<sub>2</sub>O: C, 73.23; H, 4.75; N, 7.76. Found (%): C, 73.38; H, 4.74; N, 7.71.</p><p>4g: (Z)-Nˊ-((E)-3-phenyl-1-(m-tolyl)allylidene) benzohydrazide, Yellow oil; 67% yield; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.01 (s, 1 H), 7.59 (d, J = 7.2 Hz, 1 H), 7.42-7.38 (m, 10 H ), 7.30~7.24 (m, 2 H), 6.42 (d, J = 16.6 Hz, 1 H), 2.42 (s, 3 H). Anal. Calcd. (%) for C<sub>23</sub>H<sub>20</sub>N<sub>2</sub>O: C, 81.15; H, 5.92; N, 8.23. Found(%): C, 81.26; H, 5.85; N, 8.17.</p><p>4h: (Z)-Nˊ-((E)-3-(4-fluorophenyl)-1-phenylallylidene) benzohydrazide, White solid; 85% yield; m.p. 114~116˚C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.98 (s, 1 H), 7.98~7.88 (m, 1 H), 7.74~7.27 (m, 9 H), 7.12~6.99 (m, 2 H), 6.38 (d, J = 16.4 Hz, 1 H), 2.42 (s, 3 H). Anal. Calcd.(%) for C<sub>22</sub>H<sub>17</sub>FN<sub>2</sub>O: C, 76.73; H, 4.98; N, 8.13. Found (%):C, 76.88; H, 4.74; N, 8.21.</p><p>4i: (Z)-Nˊ-((E)-3-(4-chlorophenyl)-1-phenylallylidene)benzohydrazide A White solid; 87% yield; m.p. 118~121˚C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.99 (s, 1 H), 8.01~7.94 (m, 1 H), 7.74~7.58 (m, 2 H), 7.53~7.52 (m, 9 H), 6.37 (d, J = 16.4 Hz, 1 H). Anal. Calcd.(%) for C<sub>22</sub>H<sub>17</sub>ClN<sub>2</sub>O: C, 73.23; H, 4.75; N, 7.76. Found(%): C, 73.41; H, 4.66; N, 7.62.</p><p>4j: (Z)-Nˊ-((E)-3-(4-bromophenyl)-1-phenylallylidene) benzohydrazide, Yellow solid; 65% yield; m.p. 112~114˚C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.99 (s, 1 H), 7.65-7.62 (m, 3 H), 7.55~7.53 (m, 2 H), 7.50~7.44 (m, 3 H), 7.39-7.33 (m, 4 H), 7.27~7.25 (m, 2 H), 6.35 (d, J = 16.8 Hz, 1 H). Anal. Calcd. (%) for C<sub>22</sub>H<sub>17</sub>BrN<sub>2</sub>O: C, 65.20; H, 4.23; N, 6.91. Found (%): C, 65.34; H, 4.12; N, 6.88.</p><p>4k: (Z)-Nˊ-((E)-3-(4-methoxyphenyl)-1-phenylallylidene) benzohydrazide, Yellow solid; 88% yield; m.p. 106~109˚C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.94 (s, 1 H), 7.65~7.46 (m, 6 H), 7.38~7.27 (m, 6 H), 6.86 (d, J = 8.8 Hz, 2 H), 6.37 (d, J = 16 Hz, 1 H), 3.86 (s, 3H). Anal. Calcd. (%) for C<sub>23</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub>: C, 77.51; H, 5.66; N, 7.86. Found (%): C, 77.68; H, 5.59; N, 7.78.</p><p>4l: (E)-Nˊ-((E)-4-(4-methoxyphenyl)but-3-en-2-ylidene)benzohydrazide, White solid; 92% yield; m.p. 202~204˚C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 9.01 (s, 1 H), 7.85 (s, 2 H), 7.55-7.36 (m, 5 H), 7.16-7.01 (m, 2 H), 6.99~6.88 (m, 2 H), 3.84 (s, 3 H), 2.18 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ: 165.21, 161.20, 153.58, 134.42, 133.04, 129.90, 127.87, 128.49, 127.53, 126.76, 114.47, 55.36, 29.34. MS (ESI m/z) 317.1 [(M + Na<sup>+</sup>, 100%)]. Anal. Calcd. (%) for C<sub>18</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub>: C, 73.45; H, 6.16; N, 9.52. Found (%): C, 73.52; H, 6.09; N, 9.39.</p><p>4m: (Z)-4-chloro-Nˊ-((E)-1,3-diphenylallylidene)benzohydrazide, Yellow solid; 99% yield; m.p. 175~176˚C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.91 (s, 1 H), 8.02 (s, 1 H), 7.65~7.60 (m, 3 H), 7.46-7.39 (m, 5 H), 9.34~7.26 (m, 5 H), 7.23 (s, 1 H), 7.43 (d, J = 16 Hz, 1 H). Anal. Calcd. (%) for C<sub>22</sub>H<sub>17</sub>ClN<sub>2</sub>O: C, 73.23; H, 4.75; N, 7.76. Found (%): C, 73.36; H, 4.68; N, 7.65.</p><p>4n: (Z)-4-bromo-Nˊ-((E)-1,3-diphenylallylidene) benzohydrazide, Yellow solid; 98% yield; m.p. 124~126˚C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.91 (s, 1 H), 8.02 (s, 1 H), 7.71~7.55 (m, 3 H), 7.53~7.50 (m, 2 H), 7.44~7.27 (m, 8 H), 6.43 (d, J = 16.4 Hz, 1 H). Anal. Calcd. (%) for C<sub>22</sub>H<sub>17</sub>BrN<sub>2</sub>O: C, 65.20; H, 4.23; N, 6.91. Found (%): C, 65.33; H, 4.18; N, 6.82.</p><p>4o: (Z)-Nˊ-((E)-1,3-diphenylallylidene)-4-methoxybenzohydrazide, Yellow solid; 78% yield; m.p. 204~207˚C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.92 (s, 1 H), 7.66-7.57 (m, 3 H), 7.52-7.49 (m, 2 H), 7.44-7.39 (m, 3 H), 7.35~7.27 (m, 4 H), 6.86 (d, J = 6 Hz, 2 H), 6.40 (d, J = 16.4 Hz, 1 H). Anal. Calcd. (%) for C<sub>23</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub>: C, 77.51; H, 5.66; N, 7.86. Found (%): C, 77.61; H, 5.53; N, 7.69.</p><p>4p: (Z)-2-chloro-Nˊ-((E)-1,3-diphenylallylidene) benzohydrazide, White solid; 86% yield; m.p. 163~165˚C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 9.26 (s, 1 H), 7.87~7.84 (m, 1 H), 7.60~7.52 (m, 4 H), 7.47~7.36 (m, 3 H), 7.32-7.29 (m, 6 H), 6.91 (d, J = 16.4 Hz, 1 H). Anal. Calcd.(%) for C<sub>22</sub>H<sub>17</sub>ClN<sub>2</sub>O: C, 73.23; H, 4.75; N, 7.76. Found(%): C, 73.41; H, 4.57; N, 7.59.</p><p>4q: (Z)-Nˊ-((E)-1,3-diphenylallylidene)-2-methylbenzohydrazide, Yellow oil; 85% yield; <sup>1</sup>H NMR (400 MHz, CDCl3) δ:8.57 (s, 1 H), 7.60~7.51 (m, 3 H), 7.46~7.24 (m, 9 H), 7.21~7.13 (m, 2 H), 6.40 (d, J = 16.4 Hz, 1 H). Anal. Calcd. (%) for C<sub>23</sub>H<sub>20</sub>N<sub>2</sub>O: C, 81.15; H, 5.92; N, 8.23. Found (%): C, 81.31; H, 5.79; N, 8.12.</p></sec></sec><sec id="s5"><title>3. 结果与讨论</title><sec id="s5_1"><title>3.1. 最优反应条件的筛选</title><p>以查尔酮与苯甲酰肼反应为标准反应，分别进行了催化剂种类和用量、反应溶剂种类和用量、底物配比和反应时间等条件进行了优化，结果见表1。</p><p>从表1中可以看出，在没有加入催化剂时，反应不发生(表1，Entry 1)；用杂多酸磷钨酸和磷钼酸分别催化时，磷钨酸表现出了较好的产率(表1，Entry 2)；当用MCM-41固载的磷钨酸(磷钼酸)催化反应时，产率有所降低，所以我们选定磷钨酸作为催化剂。然后进行了催化剂的量筛选，实验结果表明磷钨酸量为0.15 mmol%产率最高。在对反应溶剂筛选时，发现甲醇作为溶剂，反应产率最高，89%。为了得到更高的产率，随后考察了其它溶剂对产率的影响。结果表明其它溶剂没有醇类溶剂的效果好，而在醇类溶剂中，反应产率依然在甲醇中得到最高。确定上述反应条件后，我们对底物比例进行了考察，分别对底物查尔酮：苯甲</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Optimization of reaction conditions</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="7"  ><inline-formula><inline-graphic xlink:href="http://html.hanspub.org/file/1-2970069x9_hanspub.png" xlink:type="simple"/></inline-formula></th></tr></thead><tr><td align="center" valign="middle" >Entry</td><td align="center" valign="middle" >Catalyst</td><td align="center" valign="middle" >Solvent</td><td align="center" valign="middle" >(n) chalcone/(n) hydrazide</td><td align="center" valign="middle" >Temperature</td><td align="center" valign="middle" >Time</td><td align="center" valign="middle" >Yield(%)<sup>b</sup></td></tr><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >CH<sub>3</sub>OH</td><td align="center" valign="middle" >1:1.2</td><td align="center" valign="middle" >R.T.</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >N.R.<sup>c</sup><sup> </sup></td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >PWA (0.15 mmol%)</td><td align="center" valign="middle" >CH<sub>3</sub>OH</td><td align="center" valign="middle" >1:1.2</td><td align="center" valign="middle" >R.T.</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >89</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >PMA (0.15 mmol%)</td><td align="center" valign="middle" >CH<sub>3</sub>OH</td><td align="center" valign="middle" >1:1.2</td><td align="center" valign="middle" >R.T.</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >78</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >50 wt% PWA/MCM-41 (0.15 mmol%)</td><td align="center" valign="middle" >CH<sub>3</sub>OH</td><td align="center" valign="middle" >1:1.2</td><td align="center" valign="middle" >R.T.</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >55</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >50 wt% PMA/MCM-41 (0.15 mmol%)</td><td align="center" valign="middle" >CH<sub>3</sub>OH</td><td align="center" valign="middle" >1:1.2</td><td align="center" valign="middle" >R.T.</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >65</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >PWA (0.10 mmol%)</td><td align="center" valign="middle" >CH<sub>3</sub>OH</td><td align="center" valign="middle" >1:1.2</td><td align="center" valign="middle" >R.T.</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >52</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >PWA (0.05 mmol%)</td><td align="center" valign="middle" >CH<sub>3</sub>OH</td><td align="center" valign="middle" >1:1.2</td><td align="center" valign="middle" >R.T.</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >60</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >PWA (0.20 mmol%)</td><td align="center" valign="middle" >CH<sub>3</sub>OH</td><td align="center" valign="middle" >1:1.2</td><td align="center" valign="middle" >R.T.</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >88</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >PWA (0.15 mmol%)</td><td align="center" valign="middle" >CH<sub>2</sub>Cl<sub>2</sub></td><td align="center" valign="middle" >1:1.2</td><td align="center" valign="middle" >R.T.</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >60</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >PWA (0.15 mmol%)</td><td align="center" valign="middle" >CH<sub>3</sub>CN</td><td align="center" valign="middle" >1:1.2</td><td align="center" valign="middle" >R.T.</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >52</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >PWA (0.15 mmol%)</td><td align="center" valign="middle" >CH<sub>3</sub>C<sub>6</sub>H<sub>5 </sub></td><td align="center" valign="middle" >1:1.2</td><td align="center" valign="middle" >R.T.</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >58</td></tr><tr><td align="center" valign="middle" >12</td><td align="center" valign="middle" >PWA (0.15 mmol%)</td><td align="center" valign="middle" >CH<sub>3</sub>COOEt</td><td align="center" valign="middle" >1:1.2</td><td align="center" valign="middle" >R.T.</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >64</td></tr><tr><td align="center" valign="middle" >13</td><td align="center" valign="middle" >PWA (0.15 mmol%)</td><td align="center" valign="middle" >THF</td><td align="center" valign="middle" >1:1.2</td><td align="center" valign="middle" >R.T.</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >43</td></tr><tr><td align="center" valign="middle" >14</td><td align="center" valign="middle" >PWA (0.15 mmol%)</td><td align="center" valign="middle" >C<sub>2</sub>H<sub>5</sub>OH</td><td align="center" valign="middle" >1:1.2</td><td align="center" valign="middle" >R.T.</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >75</td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" >PWA (0.15 mmol%)</td><td align="center" valign="middle" >CH<sub>3</sub>OH</td><td align="center" valign="middle" >1:1</td><td align="center" valign="middle" >R.T.</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >75</td></tr><tr><td align="center" valign="middle" >16</td><td align="center" valign="middle" >PWA (0.15 mmol%)</td><td align="center" valign="middle" >CH<sub>3</sub>OH</td><td align="center" valign="middle" >1:1.5</td><td align="center" valign="middle" >R.T.</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >96</td></tr><tr><td align="center" valign="middle" >17</td><td align="center" valign="middle" >PWA (0.15 mmol%)</td><td align="center" valign="middle" >CH<sub>3</sub>OH</td><td align="center" valign="middle" >1:2</td><td align="center" valign="middle" >R.T.</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >80</td></tr><tr><td align="center" valign="middle" >18</td><td align="center" valign="middle" >PWA (0.15 mmol%)</td><td align="center" valign="middle" >CH<sub>3</sub>OH</td><td align="center" valign="middle" >1:1.5</td><td align="center" valign="middle" >R.T.</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >73</td></tr><tr><td align="center" valign="middle" >19</td><td align="center" valign="middle" >PWA (0.15 mmol%)</td><td align="center" valign="middle" >CH<sub>3</sub>OH</td><td align="center" valign="middle" >1:1.5</td><td align="center" valign="middle" >R.T.</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >82</td></tr><tr><td align="center" valign="middle" >20</td><td align="center" valign="middle" >PWA (0.15 mmol%)</td><td align="center" valign="middle" >CH<sub>3</sub>OH</td><td align="center" valign="middle" >1:1.5</td><td align="center" valign="middle" >R.T.</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >83</td></tr></tbody></table></table-wrap><p>表1. 反应条件的优化<sup>a</sup></p><p><sup>a</sup>反应条件：查尔酮0.1 mmol，酰肼0.15 mmol催化剂量为0.15 mmol%在0.5 mL甲醇中室温反应24 h。<sup>b</sup>柱层析产率。<sup>c</sup>N.R = No Reaction。</p><p>酰肼为1:1，1:1.2，1:1.5，1:2等比例下进行了筛选，结果见表1的Entries 14-17。从表中可以看到，随着酰肼量的增加，产率有所上升，在1:1.5时，达到96%的产率，当继续增加酰肼的量(比例为1:2)时，产率有所下降，所以最有底物比例为1:1.5。实验在常温条件下进行，这属于理想反应条件范畴。最后对反应时间进行了考察，结果列于表1的Entries 17-20。反应中，当反应时间延长到24 h时，反应产率得到最高值96%，继续延长反应时间，产率处于下降趋势。通过对实验条件的筛选，最佳反应条件为：室温下以0.15 mmol%的磷钨酸为催化剂，0.5 mL甲醇为溶剂，底物配比(查尔酮:苯甲酰肼)为1:1.5，反应24 h。</p></sec><sec id="s5_2"><title>3.2. 底物结构对反应的影响</title><p>在最佳反应条件下，对底物进行了普适性的研究，结果详见表1。</p><p>从表2中，可以看到R<sub>2</sub>上的取代基无论是吸电子基团还是供电子基团，都能够很好地得到相应的目</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Substrate scope</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Entry</th><th align="center" valign="middle" >R<sub>1</sub></th><th align="center" valign="middle" >R<sub>2</sub></th><th align="center" valign="middle" >R<sub>3</sub></th><th align="center" valign="middle" >Product</th><th align="center" valign="middle" >Yield(%)<sup>b</sup></th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >4a</td><td align="center" valign="middle" >96</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >p-ClPh</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >4b</td><td align="center" valign="middle" >92</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >p-BrPh</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >4c</td><td align="center" valign="middle" >94</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >p-CH<sub>3</sub>Ph</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >4d</td><td align="center" valign="middle" >83</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >p-OCH<sub>3</sub>Ph</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >4e</td><td align="center" valign="middle" >90</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >m-ClPh</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >4f</td><td align="center" valign="middle" >75</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >m-CH<sub>3</sub>Ph</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >4g</td><td align="center" valign="middle" >67</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >p-FPh</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >4h</td><td align="center" valign="middle" >85</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >p-ClPh</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >4i</td><td align="center" valign="middle" >87</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >p-BrPh</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >4j</td><td align="center" valign="middle" >65</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >p-OCH<sub>3</sub>Ph</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >4k</td><td align="center" valign="middle" >88</td></tr><tr><td align="center" valign="middle" >12</td><td align="center" valign="middle" >p-OCH<sub>3</sub>Ph</td><td align="center" valign="middle" >CH<sub>3</sub></td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >4l</td><td align="center" valign="middle" >92</td></tr><tr><td align="center" valign="middle" >13</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >p-ClPh</td><td align="center" valign="middle" >4m</td><td align="center" valign="middle" >99</td></tr><tr><td align="center" valign="middle" >14</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >p-BrPh</td><td align="center" valign="middle" >4n</td><td align="center" valign="middle" >98</td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >p-OCH<sub>3</sub>Ph</td><td align="center" valign="middle" >4o</td><td align="center" valign="middle" >78</td></tr><tr><td align="center" valign="middle" >16</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >o-ClPh</td><td align="center" valign="middle" >4p</td><td align="center" valign="middle" >86</td></tr><tr><td align="center" valign="middle" >17</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >Ph</td><td align="center" valign="middle" >o-CH<sub>3</sub>Ph</td><td align="center" valign="middle" >4q</td><td align="center" valign="middle" >85</td></tr></tbody></table></table-wrap><p>表2. 底物结构的拓展<sup>a</sup></p><p><sup>a</sup>反应条件：查尔酮0.1 mmol，酰肼0.15 mmol催化剂量为0.004 g在0.5 mL甲醇中室温反应24 h。<sup>b</sup>柱层析产率。</p><p>标产物；当同种取代基苯环上的位置不同时，其产率也有很大的变化，而且对位取代的产率要高于间位取代，如R<sub>2</sub>，氯取代对位时的产率要高于其间位取代(Entries 2, 6)，对甲基比间甲基的产率高(Entries 4, 7)。对于R<sub>1</sub>苯环上的取代基，除了Br取代产率较低外，其它产率都能达到85%以上。在酰肼R<sub>3</sub>取代基的改变中，从表中可以看出，对位和邻位取代的酰肼都获得了较高的产率。</p></sec></sec><sec id="s6"><title>4. 结论</title><p>本文研究了查尔酮和酰肼的缩合反应。通过优化实验，最终得出了最优反应条件：0.004 g磷钨酸为催化剂、底物配比为1:1.5(查尔酮:酰肼)，甲醇为溶剂，室温下反应24 h。在该反应条件下，获得了一系列高产率的酰腙类目标产物，最高产率达到99%。本反应具有反应条件温和，催化剂廉价易得等优点。</p></sec><sec id="s7"><title>基金项目</title><p>国家自然科学基金(Nos. 21161026, 21362036)。</p></sec><sec id="s8"><title>文章引用</title><p>吴 阳,邢雪建,邢刘桩,侯亚东,杨敬辉,惠永海. 磷钨酸促进的酰肼与查尔酮缩合反应的研究 Study on the Condensation Reaction of Hydrazide with Benzylideneacetophenone Catalyzed by Phosphotungstic Acid[J]. 有机化学研究, 2016, 04(04): 93-99. http://dx.doi.org/10.12677/JOCR.2016.44013</p></sec><sec id="s9"><title>参考文献 (References)</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.19131-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Rollas, S. and Küçükgüzel, S.G. (2007) Biological Activities of Hydrazone Derivatives. Molecules, 12, 1910-1939.  
https://doi.org/10.3390/12081910</mixed-citation></ref><ref id="hanspub.19131-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Vicini, P., Zani, F., Cozzini, P. and Doytchinova, I. (2002) Hydrazones of 1, 2-Benzisothiazole Hydrazides: Synthesis, Antimicrobial Activity and QSAR Investigations. European Journal of Medicinal Chemistry, 37, 553-564.  
https://doi.org/10.1016/S0223-5234(02)01378-8</mixed-citation></ref><ref id="hanspub.19131-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Jayabharathi, J., Thangamani, A., Padmavathy, M. and Krishnakumar, B. (2007) Synthesis and Microbial Evaluation of Novel n (1)-arilidene-n (2)-t (3)-methyl-r(2), c (6)-diaryl-piperidin-4-one Azine Derivatives. Medicinal Chemistry Research, 15, 431-442. https://doi.org/10.1007/s00044-006-0014-0</mixed-citation></ref><ref id="hanspub.19131-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Ragavendran, J.V., Sriram, D., Patel, S.K., Reddy, I.V., Bharathwajan, N. and Stables, J. (2007) Design and Synthesis of Anticonvulsants from a Combined Phthalimide-Gaba-Anilide and Hydrazone Pharmacophore. European Journal of Medicinal Chemistry, 42, 146-151. https://doi.org/10.1016/j.ejmech.2006.08.010</mixed-citation></ref><ref id="hanspub.19131-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">El-Hawash, S.A.M., Wahab, A.E.A. and El-Demellawy, M.A. (2006) Cyanoacetic Acid Hydrazones of 3-(and 4-)acetylpyridine and Some Derived Ring Systems as Potential Antitumor and Anti-HCV Agents. Archiv Der Pharmazie, 339, 14-23. https://doi.org/10.1002/ardp.200500161</mixed-citation></ref><ref id="hanspub.19131-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Todeschini, A.R., Miranda, A.L.P.D., Silva, K.C.M.D., Parrini, S.C. and Barreiro, E.J. (1998) Synthesis and Evaluation of Analgesic, Antiinflammatory and Antiplatelet Properties of New 2-Pyridylarylhydrazone Derivatives. European Journal of Medicinal Chemistry, 33, 189-199. https://doi.org/10.1016/S0223-5234(98)80008-1</mixed-citation></ref><ref id="hanspub.19131-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Nath, M., Vats, M. and Roy, P. (2013) Tri- and Diorganotin(iv) Complexes of Biologically Important Orotic Acid: Synthesis, Spectroscopic Studies, In Vitro Anti-Cancer, DNA Fragmentation, Enzyme Assays and In Vivo Anti-Inflammatory Activities. European Journal of Medicinal Chemistry, 59, 310-321.  
https://doi.org/10.1016/j.ejmech.2012.11.023</mixed-citation></ref><ref id="hanspub.19131-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Despaigne, A.A.R., Costa, F.B.D., Piro, O.E., Castellano, E.E., Louro, S.R.W. and Beraldo, H. (2012) Complexation of 2-Acetylpyridine- and 2-Benzoylpyridine-Derived Hydrazones to Copper (ii) as an Effective Strategy for Antimicrobial Activity Improvement. Polyhedron, 38, 285-290. https://doi.org/10.1016/j.poly.2012.03.017</mixed-citation></ref><ref id="hanspub.19131-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Xu, Z.H., Zhang, X.W., Zhang, W.Q., Gao, Y.H. and Zeng, Z.Z. (2011) Synthesis, Characterization, DNA Interaction and Antibacterial Activities of Two Tetranuclear Cobalt (ii) and Nickel (ii) Complexes with Salicylaldehyde 2-Phenylquinoline-4-Carboylhydrazone. Inorganic Chemistry Communications, 14, 1569-1573.  
https://doi.org/10.1016/j.inoche.2011.06.005</mixed-citation></ref><ref id="hanspub.19131-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">El-Sayed, L., Iskander, M.F., Hawash, N.M. and Massoud, S.S. (1998) Synthesis and Characterization of Nickel(ii), Zinc(ii), Copper(ii), Cobalt(ii) and Cobalt(iii) complexes of α-Dicarbonylbis(aroylhydrazone). Polyhedron, 17, 199-206. https://doi.org/10.1016/S0277-5387(97)00191-5</mixed-citation></ref><ref id="hanspub.19131-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Lal, R.A., Adhikari, S., Pal, A., Siva, A.N. and Ku-mar, A. (1997) Synthesis and Characterization of the Homobimetallic [bis(2-hydroxy-1-naphthaldehyde)oxaloyldihydrazonato]bis(dioxomolybdenum(vi)) Tetrahydrate Complex and Its Reactivity towards Proton and Electron Donor Reagents. Journal of Chemical Research, 4, 122-123.  
https://doi.org/10.1039/a506810j</mixed-citation></ref><ref id="hanspub.19131-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Aboraia, A.S., Yee, S.W., Gomaa, M.S., Shah, N., Robotham, A.C. and Makowski, B. (2010) Synthesis and CYP24AL Inhibitory Activity of N-(2-(1H-imidazol-1-yl)-2-phenylethyl)arylamides. Bioorganic &amp; Medicinal Chemistry, 18, 4939-4946. https://doi.org/10.1016/j.bmc.2010.06.011</mixed-citation></ref><ref id="hanspub.19131-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Fatmawati, S., Kondo, R. and Shimizu, K. (2013) Structure-Activity Relationships of Lanostane-Type Triterpenoids from Ganoderma Lingzhi, as α-Glucosidase Inhibitors. Bioorganic &amp; Medicinal Chemistry Letters, 23, 5900-5903.  
https://doi.org/10.1016/j.bmcl.2013.08.084</mixed-citation></ref><ref id="hanspub.19131-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Ma, J., Shi, W., Feng, L., Chen, Y., Fan, K. and Hao, Y. (2016) A Highly Selective and Sensitive Acylhydrazone- Based Turn-On optical Sensor for Al3+. RSC Advances, 6, 28034-28037. https://doi.org/10.1039/C6RA01589A</mixed-citation></ref><ref id="hanspub.19131-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Hu, J.H., Li, J.B., Qi, J. and Sun, Y. (2015) Acylhydrazone Based Fluorescent Chemosensor for Zinc in Aqueous Solution with High Selectivity and Sensitivity. Sensors &amp; Actuators B Chemical, 208, 581-587.  
https://doi.org/10.1016/j.snb.2014.11.066</mixed-citation></ref><ref id="hanspub.19131-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">李在国, 王清民, 黄君珉. 有机中间体制备[M]. 第二版. 北京: 化学工业出版社, 1996: 51.</mixed-citation></ref></ref-list></back></article>